|
|
| | BIIB068 Basic information |
| Product Name: | BIIB068 | | Synonyms: | BIIB068;BIIB-068;1-Azetidinecarboxamide, 3-(1-methylethoxy)-N-[[2-methyl-4-[2-[(1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]phenyl]methyl]-;ADME,inhibit,FcγR,Autoimmune,Bruton tyrosine kinase,TNFα,BIIB 068,ROS,Inhibitor,reversible,Btk,anti-IgD,phosphorylation,BIIB068,anti-IgM,BIIB-068;N-[(2-methyl-4-{2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}phenyl)methyl]-3-(propan-2-yloxy)azetidine-1-carboxamide | | CAS: | 1798787-27-5 | | MF: | C23H29N7O2 | | MW: | 435.52 | | EINECS: | | | Product Categories: | | | Mol File: | 1798787-27-5.mol |  |
| | BIIB068 Chemical Properties |
| density | 1.30±0.1 g/cm3(Predicted) | | solubility | DMSO:30.63(Max Conc. mg/mL);70.33(Max Conc. mM)
DMSO:PBS (pH 7.2) (1:4):0.2(Max Conc. mg/mL);0.46(Max Conc. mM)
DMF:30.0(Max Conc. mg/mL);68.88(Max Conc. mM)
Ethanol:10.0(Max Conc. mg/mL);22.96(Max Conc. mM) | | form | A crystalline solid | | pka | 13.40±0.40(Predicted) |
| | BIIB068 Usage And Synthesis |
| | BIIB068 Preparation Products And Raw materials |
|